What does Traversalgo do?

Traversalgo is a specialist medical practice in Overijse. Private Limited, started on 17 November 2011, 1 establishment.

What is the address of Traversalgo?

The registered office of Traversalgo is located at Jean Tombeurstraat 19 box a, 3090 Overijse.

Is Traversalgo still active?

Yes. According to the CBE (15 November 2026) Traversalgo is active, legal situation “Normale toestand”, started on 17 November 2011.

Is Traversalgo registered on Peppol?

Yes, Traversalgo is registered on the Peppol network with ID 0208:0841104915.

What is the enterprise number of Traversalgo?

The enterprise number of Traversalgo is BE0841104915.

When was Traversalgo founded?

Traversalgo was founded on 17 November 2011.

Who are the directors of Traversalgo?

According to the 2025 annual accounts, the directors of Traversalgo are: Hilde CALLEWAERT.

Is Traversalgo a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 17 November 2011; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account; 1 events from the Belgian Official Gazette processed.

How much profit did Traversalgo make in 2025?

Traversalgo posted a profit after taxes of € 121,561 in financial year 2025.

What is the revenue of Traversalgo?

As a small company, Traversalgo is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 247,825.

Traversalgo (Private Limited) - Overijse - BE0841104915

Dossier Traversalgo, printed on 15 November 2026 from databakkes.be/en/0841104915/traversalgo. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 54 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

Traversalgo from Overijse, company number BE0841104915, closed financial year 2025 with a result of € 121,561 after tax. For that financial year Traversalgo recorded a gross margin of € 247,825 and equity of € 425,673. Compared with financial year 2024, the result moved from € 109,955 to € 121,561. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on October 7, 2026.

What it is worth Healthy

€ 425,673

▼ 40% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 121,561

▲ 11% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 209,744

▲ 39% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 409,892 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Vehicles and equipment

€ 13,441

▼ 44% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

€ 4,678

▼ 70% vs 2024

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 6,069

▲ 4% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 51,455

▲ 21% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 198,293 Gross margin 2022: € 198,293 First fiscal year in the series	€ 190,412 Gross margin 2023: € 190,412 ▼ 4% vs 2022 (€ 198,293) Unfavourable step	€ 234,590 Gross margin 2024: € 234,590 ▲ 23% vs 2023 (€ 190,412) Favourable step	€ 247,825 Gross margin 2025: € 247,825 ▲ 6% vs 2024 (€ 234,590) Favourable step	▲ 6%
Profit after taxes	€ 77,538 Profit after taxes 2022: € 77,538 First fiscal year in the series	€ 70,691 Profit after taxes 2023: € 70,691 ▼ 9% vs 2022 (€ 77,538) Unfavourable step	€ 109,955 Profit after taxes 2024: € 109,955 ▲ 56% vs 2023 (€ 70,691) Favourable step	€ 121,561 Profit after taxes 2025: € 121,561 ▲ 11% vs 2024 (€ 109,955) Favourable step	▲ 11%
Equity	€ 535,023 Equity 2022: € 535,023 First fiscal year in the series	€ 604,881 Equity 2023: € 604,881 ▲ 13% vs 2022 (€ 535,023) Favourable step	€ 714,003 Equity 2024: € 714,003 ▲ 18% vs 2023 (€ 604,881) Favourable step	€ 425,673 Equity 2025: € 425,673 ▼ 40% vs 2024 (€ 714,003) Unfavourable step	▼ 40%
Total debts	€ 171,340 Total debts 2022: € 171,340 First fiscal year in the series	€ 180,187 Total debts 2023: € 180,187 ▲ 5% vs 2022 (€ 171,340) Unfavourable step	€ 158,684 Total debts 2024: € 158,684 ▼ 12% vs 2023 (€ 180,187) Favourable step	€ 530,546 Total debts 2025: € 530,546 ▲ 234% vs 2024 (€ 158,684) Unfavourable step	▲ 234%
Cash	€ 33,945 Cash 2022: € 33,945 First fiscal year in the series	€ 102,767 Cash 2023: € 102,767 ▲ 203% vs 2022 (€ 33,945) Favourable step	€ 151,238 Cash 2024: € 151,238 ▲ 47% vs 2023 (€ 102,767) Favourable step	€ 209,744 Cash 2025: € 209,744 ▲ 39% vs 2024 (€ 151,238) Favourable step	▲ 39%
Retained profit	€ 522,623 Retained profit 2022: € 522,623 First fiscal year in the series	€ 592,481 Retained profit 2023: € 592,481 ▲ 13% vs 2022 (€ 522,623) Favourable step	€ 701,603 Retained profit 2024: € 701,603 ▲ 18% vs 2023 (€ 592,481) Favourable step	€ 413,273 Retained profit 2025: € 413,273 ▼ 41% vs 2024 (€ 701,603) Unfavourable step	▼ 41%
Dividend	€ 800 Dividend 2022: € 800 First fiscal year in the series	€ 833 Dividend 2023: € 833 ▲ 4% vs 2022 (€ 800) Unchanged	€ 833 Dividend 2024: € 833 Unchanged (€ 833) Unchanged	€ 409,892 Dividend 2025: € 409,892 ▲ € 409,059 vs 2024 (€ 833) Unchanged	▲ € 409,059
Bank debt	€ 37,405 Bank debt 2022: € 37,405 First fiscal year in the series	€ 26,680 Bank debt 2023: € 26,680 ▼ 29% vs 2022 (€ 37,405) Favourable step	€ 15,772 Bank debt 2024: € 15,772 ▼ 41% vs 2023 (€ 26,680) Favourable step	€ 4,678 Bank debt 2025: € 4,678 ▼ 70% vs 2024 (€ 15,772) Favourable step	▼ 70%
Balance sheet total	€ 706,362 Balance sheet total 2022: € 706,362 First fiscal year in the series	€ 785,068 Balance sheet total 2023: € 785,068 ▲ 11% vs 2022 (€ 706,362) Unchanged	€ 872,687 Balance sheet total 2024: € 872,687 ▲ 11% vs 2023 (€ 785,068) Unchanged	€ 956,218 Balance sheet total 2025: € 956,218 ▲ 10% vs 2024 (€ 872,687) Unchanged	▲ 10%

By gross margin, Traversalgo ranks 10th of 32 companies with main activity “Activiteiten van medisch specialisten” in Overijse that publish figures (fiscal year 2025).

Key figures of Traversalgo, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

Ask about Traversalgo the way you would ask their accountant.

Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.

Connect ChatGPT or Claude for free

ChatGPT
Claude

Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.

What happened to Traversalgo?

What happened at Traversalgo in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Oct 7, 2026 New annual accounts for financial year 2025: profit of € 121,561 (▲ 11% vs 2024). filed late Source: NBB ↗
Nov 29, 2011 Incorporation, published in the Gazette. Source: Staatsblad ↗
Nov 14, 2011 New establishment in Vilvoorde. KBO
2011 Hilde CALLEWAERT became a director. NBB

In short

From € 77,538 profit in 2022 to € 121,561 profit in 2025.

Paid € 150,301 in corporate taxes since 2022.

Best year ever: 2025, with € 121,561 profit.

Paid out € 412,358 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Hilde CALLEWAERT

Traversalgo

Behind Traversalgo is Hilde CALLEWAERT.

Directors

According to the 2025 annual accounts

Hilde CALLEWAERT

Director

since 2011

Establishments

Establishment units

Physical locations of this company

Registered office

Jean Tombeurstraat 19 box a

3090 Overijse

2.303.539.271

Gendarmeriestraat 65

1800 Vilvoorde

Active since 14 November 2011

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

Pianite

€ 278,698 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Similar companies in Overijse

Same main activity (Activiteiten van medisch specialisten), 34 active companies in Overijse, largest first.

Beclinic

€ 1.9 million gross margin · 2025

DR. TESSA DE WANDELER RADIOLOGIE

€ 507,953 gross margin · 2025

BF Resp Oncology

€ 422,084 gross margin · 2025

GRANDJEAN FREDERIC DOCTEUR

€ 384,143 gross margin · 2025

MAPIALEJ

€ 334,553 gross margin · 2025

Dr. Reynaert MDL

€ 293,636 gross margin · 2025

All companies with this activity → Largest companies in Overijse →

Shareholders according to the Official Gazette deeds

Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.

Incorporation

29 November 2011 Source: Deed ↗

CALLEWAERT Hilde(oprichtster) 100%

Details

Company number: 0841.104.915
VAT number: BE 0841.104.915
Registered office: Jean Tombeurstraat 19 bus a, 3090 Overijse
Names & denominations: Traversalgo
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 17 November 2011
Peppol: Active · Active since 3 Jan 2026
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗